CD163
関連文献

“Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update”. J Cereb Blood Flow Metab 40 (9):  1752–1768. (May 2020). doi:10.1177/0271678X20923551. PMC 7446569. PMID 32423330. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446569/.
“CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma”. The International Journal of Biochemistry & Cell Biology 34 (4):  309–14. (April 2002). doi:10.1016/S1357-2725(01)00144-3. PMID 11854028.
“Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes”. Redox Report 6 (6):  386–8. (2002). doi:10.1179/135100001101536490. PMID 11865982.
“CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response”. Annals of Medicine 36 (5):  347–54. (2005). doi:10.1080/07853890410033171. PMID 15478309.
“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene 138 (1–2):  171–4. (January 1994). doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
“A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily”. European Journal of Immunology 23 (9):  2320–5. (September 1993). doi:10.1002/eji.1830230940. PMID 8370408.
“Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene 200 (1–2):  149–56. (October 1997). doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
“Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family”. Biochemical and Biophysical Research Communications 256 (1):  110–3. (March 1999). doi:10.1006/bbrc.1999.0294. PMID 10066432.
“Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily”. Biochemical and Biophysical Research Communications 260 (2):  466–74. (July 1999). doi:10.1006/bbrc.1999.0866. PMID 10403791.
“Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation”. Journal of Leukocyte Biology 66 (5):  858–66. (November 1999). doi:10.1002/jlb.66.5.858. PMID 10577520.
“Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli”. Journal of Leukocyte Biology 67 (1):  97–103. (January 2000). doi:10.1002/jlb.67.1.97. PMID 10648003.
“Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis”. Cytogenetics and Cell Genetics 90 (3–4):  246–7. (2001). doi:10.1159/000056781. PMID 11124526.
“Identification of the haemoglobin scavenger receptor”. Nature 409 (6817):  198–201. (January 2001). Bibcode: 2001Natur.409..198K. doi:10.1038/35051594. PMID 11196644.
“Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C”. European Journal of Immunology 31 (4):  999–1009. (April 2001). doi:10.1002/1521-4141(200104)31:4<999::AID-IMMU999>3.0.CO;2-R. PMID 11298324.
“Development of an ELISA to measure soluble CD163 in biological fluids”. Journal of Immunological Methods 252 (1–2):  25–31. (June 2001). doi:10.1016/S0022-1759(01)00328-3. PMID 11334962.
“Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation”. Biochemical and Biophysical Research Communications 288 (4):  841–3. (November 2001). doi:10.1006/bbrc.2001.5845. PMID 11688984.
“Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments”. Arthritis and Rheumatism 46 (5):  1210–6. (May 2002). doi:10.1002/art.10207. PMID 12115225.
“Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect”. FEBS Letters 526 (1–3):  93–6. (August 2002). doi:10.1016/S0014-5793(02)03142-3. PMID 12208511.
“Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3”. Clinical and Experimental Immunology 130 (1):  156–61. (October 2002). doi:10.1046/j.1365-2249.2002.01963.x. PMC 1906487. PMID 12296867. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906487/.